Last reviewed · How we verify

midazolam in children premedication

Azienda Ospedaliera Universitaria Policlinico "G. Martino" · FDA-approved active Small molecule

midazolam in children premedication is a Benzodiazepine Small molecule drug developed by Azienda Ospedaliera Universitaria Policlinico "G. Martino". It is currently FDA-approved for Premedication and anxiolysis in children undergoing surgical or diagnostic procedures, Sedation in pediatric patients.

Midazolam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to produce sedation and anxiolysis.

Midazolam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to produce sedation and anxiolysis. Used for Premedication and anxiolysis in children undergoing surgical or diagnostic procedures, Sedation in pediatric patients.

At a glance

Generic namemidazolam in children premedication
SponsorAzienda Ospedaliera Universitaria Policlinico "G. Martino"
Drug classBenzodiazepine
TargetGABA-A receptor
ModalitySmall molecule
Therapeutic areaAnesthesia/Sedation
PhaseFDA-approved

Mechanism of action

Midazolam binds to benzodiazepine receptors on GABA-A receptors, increasing the frequency of chloride channel opening and hyperpolarizing neuronal membranes. This results in reduced neuronal excitability and produces sedative, anxiolytic, and amnestic effects. In pediatric premedication, it reduces anxiety and facilitates smoother induction of anesthesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about midazolam in children premedication

What is midazolam in children premedication?

midazolam in children premedication is a Benzodiazepine drug developed by Azienda Ospedaliera Universitaria Policlinico "G. Martino", indicated for Premedication and anxiolysis in children undergoing surgical or diagnostic procedures, Sedation in pediatric patients.

How does midazolam in children premedication work?

Midazolam is a benzodiazepine that enhances inhibitory GABAergic neurotransmission in the central nervous system to produce sedation and anxiolysis.

What is midazolam in children premedication used for?

midazolam in children premedication is indicated for Premedication and anxiolysis in children undergoing surgical or diagnostic procedures, Sedation in pediatric patients.

Who makes midazolam in children premedication?

midazolam in children premedication is developed and marketed by Azienda Ospedaliera Universitaria Policlinico "G. Martino" (see full Azienda Ospedaliera Universitaria Policlinico "G. Martino" pipeline at /company/azienda-ospedaliera-universitaria-policlinico-g-martino).

What drug class is midazolam in children premedication in?

midazolam in children premedication belongs to the Benzodiazepine class. See all Benzodiazepine drugs at /class/benzodiazepine.

What development phase is midazolam in children premedication in?

midazolam in children premedication is FDA-approved (marketed).

What are the side effects of midazolam in children premedication?

Common side effects of midazolam in children premedication include Respiratory depression, Hypotension, Paradoxical agitation, Oversedation, Emergence delirium.

What does midazolam in children premedication target?

midazolam in children premedication targets GABA-A receptor and is a Benzodiazepine.

Related